Abstract
The computational analysis of millions of unannotated SNPs from the 1000 Genomes Project may speed up the search for biomedical SNP markers. We combined the analysis of SNPs at the binding sites of the TATA-binding protein (TBP) using a previously described Web service (http://beehive.bionet.nsc.ru/cgi-bin/mgs/tatascan/start.pl) with a keyword search for biochemical markers of chronopathologies that correspond to the clinical manifestations of these SNPs. We found 32 known and candidate SNP markers of circadian-rhythm disturbances in the [–70;–20] region of the promoters of 14 human genes (location of proven binding sites of TBP). These SNPs include rs17231520 and rs569033466 (both confer risk of chronopathologies in the liver); rs35036378 (behavioral chronoaberrations); rs549858786 (rheumatoid arthritis with a chronoaberration of IL1B expression); rs563207167, rs11557611, and rs5505 (all three: chronopathologies of the tumor—host balance, blood pressure, and the reproductive system); rs1143627 (bipolar disorder with circadian dependence of diagnosis and treatment); rs16887226 and rs544850971 (both: lowered resistance to endotoxins because of the imbalance between the circadian and immune systems); rs367732974 and rs549591993 (both: circadian dependence of heart attacks); rs563763767 (circadian dependence of myocardial infarction); rs2276109 and rs572527200 (both: circadian dependence of asthma attacks); rs34223104, rs563558831, and rs10168 (circadian optima of treatment with methotrexate and cyclophosphamide); and rs397509430, rs33980857, rs34598529, rs33931746, rs33981098, rs34500389, rs63750953, rs281864525, rs35518301, and rs34166473 (all: neurosensory hearing loss and restless legs syndrome). For these SNPs, we evaluated the α (significance) of changes in the affinity of TBP for promoters, where increased affinity corresponds to overexpression of the genes, and decreased affinity to deficient expression (Z-test). Verification of these 32 SNP markers according to the clinical standards and protocols may advance the field of predictive preventive personalized medicine.
Similar content being viewed by others
References
Abbas, A., Lechevrel, M., and Sichel, F., Identification of new single nucleotide polymorphisms (SNP) in alcohol dehydrogenase class IVADH7 gene within a French population, Arch. Toxicol., 2006, vol. 80, no. 4, pp. 201–205. doi 10.1007/s00204-005-0031-7
Al-Shakfa, F., Dulucq, S., Brukner, I., Milacic, I., Ansari, M., Beaulieu, P., Moghrabi, A., Laverdiere, C., Sallan, S., Silverman, L.B., Neuberg, D., Kutok, J.L., Sinnett, D., and Krajinovic, M., DNA variants in region for noncoding interfering transcript of dihydrofolate reductase gene and outcome in childhood acute lymphoblastic leukemia, Clin. Cancer Res., 2009, vol. 15, no. 22, pp. 6931–6938. doi 10.1158/1078-0432.CCR-09-0641
Arkova, O.V., Kuznetsov, N.A., Fedorova, O.S., Kolchanov, N.A., and Savinkova, L.K., Real-Time Interaction between TBP and the TATA Box of the Human Triosephosphate Isomerase Gene Promoter in the Norm and Pathology, Acta Naturae, 2014, vol. 6, no. 2, pp. 36–40.
Arnaud, E., Barbalat, V., Nicaud, V., Cambien, F., Evans, A., Morrison, C., Arveiler, D., Luc, G., Ruidavets, J.B., Emmerich, J., Fiessinger, J.N., and Aiach, M., Polymorphisms in the 5' regulatory region of the tissue factor gene and the risk of myocardial infarction and venous thromboembolism: The ECTIM and PATHROS studies. Etude Cas-Temoins de L’Infarctus du Myocarde, Paris thrombosis case-control study, Arterioscler. Thromb. Vasc. Biol., 2000, vol. 20, no. 3, pp. 892–898.
Ávila Moraes, C., Cambras, T., Diez-Noguera, A., Schimitt, R., Dantas, G., Levandovski, R., and Hidalgo, M.P., A new chronobiological approach to discriminate between acute and chronic depression using peripheral temperature, rest-activity, and light exposure parameters, BMC Psychiatry, 2013, vol. 13, p. 77. doi 10.1186/1471-244X-13-77
Bannerman, R.M., Garrick, L.M., Rusnak-Smalley, P., Hoke, J.E., and Edwards, J.A., Hemoglobin deficit: An inherited hypochromic anemia in the mouse, Proc. Soc. Exp. Biol. Med., 1986, vol. 182, no. 1, pp. 52–57.
Bianchi, S., Bigazzi, R., Nenci, R., and Campese, V., Hyperinsulinemia, circadian variation of blood pressure and end-organ damage in hypertension, J. Nephrol., 1997, vol. 10, no. 6, pp. 325–333.
Binkhorst, L., Kloth, J.S., de Wit, A.S., de Bruijn, P., Lam, M.H., Chaves, I., Burger, H., van Alphen, R.J., Hamberg, P., van Schaik, R.H., Jager, A., Koch, B.C., Wiemer, E.A., van Gelder, T., van der Horst, G.T., and Mathijssen, R.H., Circadian variation in tamoxifen pharmacokinetics in mice and breast cancer patients, Breast Cancer Res. Treat, 2015, vol. 152, no. 1, pp. 119–128. doi 10.1007/s10549-015-3452-x
Blask, D., Dauchy, R., Dauchy, E., Mao, L., Hill, S.M., Greene, M.W., Belancio, V.P., Sauer, L.A., and Davidson, L., Light exposure at night disrupts host/cancer circadian regulatory dynamics: Impact on the Warburg effect, lipid signaling and tumor growth prevention, PLoS One, 2014, vol. 9, no. 8. doi 10.1371/journal.pone.0102776
Borkowska, P., Kucia, K., Rzezniczek, S., Paul-Samojedny, M., Kowalczyk, M., Owczarek, A., Suchanek, R., Medrala, T., and Kowalski, J., Interleukin-1beta promoter (–31T/C and–511C/T) polymorphisms in major recurrent depression, J. Mol. Neurosci., 2011, vol. 44, no. 1, pp. 12–16.
Carter, C.J., Multiple genes and factors associated with bipolar disorder converge on growth factor and stress activated kinase pathways controlling translation initiation: Implications for oligodendrocyte viability, Neurochem. Int., 2007, vol. 50, no. 3, pp. 461–490. doi 10.1016/j.neuint.2006.11.009
Carvalho de Sousa, J., Bruckert, E., Giral, P., Soria, C., Chapman, J., Truffert, J., Dairou, F., DeGennes, J.L., and Caen, J.P., Coagulation factor VII and plasma triglycerides. Decreased catabolism as a possible mechanism of factor VII hyperactivity, Haemostasis, 1989, vol. 19, no. 3, pp. 125–130.
Casal, A., Sinclair, V., Capponi, A.M., Nicod, J., Huynh-Do, U., and Ferrari, P., A novel mutation in the steroidogenic acute regulatory protein gene promoter leading to reduced promoter activity, J. Mol. Endocrinol., 2006, vol. 37, no. 1, pp. 71–80. doi 10.1677/jme.1.02082
Cash, E., Sephton, S.E., Chagpar, A.B., Spiegel, D., Rebholz, W.N., Zimmaro, L.A., Tillie, J.M., and Dhabhar, F.S., Circadian disruption and biomarkers of tumor progression in breast cancer patients awaiting surgery, Brain Behav. Immun., 2015, vol. 48, pp. 102–114. doi 10.1016/j.bbi.2015.02.017
Chen, C.Y., Chang, I.S., Hsiung, C.A., and Wasserman, W.W., On the identification of potential regulatory variants within genome wide association candidate SNP sets, BMC Med. Genomics, 2014, vol. 11, no. 7, p. 34. doi 10.1186/1755-8794-7-34
Chikanza, I.C., Petrou, P., Kingsley, G., Chrousos, G., and Panayi, G.S., Defective hypothalamic response to immune and inflammatory stimuli in patients with rheumatoid arthritis, Arthritis Rheum., 1992, vol. 35, no. 11, pp. 1281–1288.
Choukrallah, M.A., Kobi, D., Martianov, I., Pijnappel, W.W., Mischerikow, N., Ye, T., Heck, A.J., Timmers, H.T., and Davidson, I., Interconversion between active and inactive TATA-binding protein transcription complexes in the mouse genome, Nucleic Acids Res., 2012, vol. 40, no. 4, pp. 1446–1459. doi 10.1093/nar/gkr802
Clark, I., Rockett, K.A., and Burgner, D., Genes, nitric oxide and malaria in African children, Trends Parasitol., 2003, vol. 19, no. 8, pp. 335–337. doi 10.1016/S1471-4922(03)00147-8
Colognesi, I., Pasquali, V., Foa, A., Renzi, P., Bernardi, F., Bertolucci, C., and Pinotti, M., Temporal variations of coagulation factor VII activity in mice are influenced by lighting regime, Chronobiol. Int., 2007, vol. 24, pp. 305–313. doi 10.1080/07420520701282307
Delaneau, O. and Marchini, J., and 1000 Genomes Project Consortium, Integrating sequence and array data to create an improved 1000 Genomes Project haplotype reference panel, Nat. Commun., 2014, vol. 5, p. 3934. doi 10.1038/ncomms4934
Drachkova, I., Savinkova, L., Arshinova, T., Ponomarenko, M., Peltek, S., and Kolchanov, N., The mechanism by which TATA-box polymorphisms associated with human hereditary diseases influence interactions with the TATAbinding protein, Hum. Mutat., 2014, vol. 35, no. 5, pp. 601–608. doi 10.1002/humu.22535
Durrington, H.J., Farrow, S.N., Loudon, A.S., and Ray, D.W., The circadian clock and asthma, Thorax, 2014, vol. 69, no. 1, pp. 90–92. doi 10.1136/thoraxjnl-2013-203482
Eckel-Mahan, K. and Sassone-Corsi, P., Epigenetic regulation of the molecular clockwork, Prog. Mol. Biol. Transl. Sci., 2013, vol. 119, pp. 29–50. doi 10.1016/B978-0-12- 396971-2.00002-6
El-Omar, E.M., Carrington, M., Chow, W.H., McColl, K.E., Bream, J.H., Young, H.A., Herrera, J., Lissowska, J., Yuan, C.C., Rothman, N., Lanyon, G., Martin, M., Fraumeni, J.F., Jr., and Rabkin, C.S., Interleukin-1 polymorphisms associated with increased risk of gastric cancer, Nature, 2000, vol. 404, no. 6776, pp. 398–402. doi 10.1038/35006081
Frankish, A., Uszczynska, B., Ritchie, G.R., Gonzalez, J.M., Pervouchine, D., Petryszak, R., Mudge, J., Fonseca, N., Brazma, A., Guigo, R., and Harrow, J., Comparison of GENCODE and RefSeq gene annotation and the impact of reference geneset on variant effect prediction, BMC Genomics, 2015, vol. 16, no. 8, p. S2. doi 10.1186/1471-2164-16-S8-S2
Gabas-Rivera, C., Martinez-Beamonte, R., Rios, J.L., Navarro, M.A., Surra, J.C., Arnal, C., Rodriguez-Yoldi, M., and Osada, J., Dietary oleanolic acid mediates circadian clock gene expression in liver independently of diet and animal model but requires apolipoprotein A1, J. Nutr. Biochem., 2013, vol. 24, pp. 2100–2109. doi 10.1016/j.jnutbio.2013.07.010
Gonzalez-Martinez, J.A., Moddel, G., Ying, Z., Prayson, R.A., Bingaman, W.E., and Najm, I.M., Neuronal nitric oxide synthase expression in resected epileptic dysplastic neocortex, J. Neurosurg., 2009, vol. 110, no. 2, pp. 343–349. doi 10.3171/2008.6.17608
Gorbacheva, V., Kondratov, R.V., Zhang, R., Cherukuri, S., Gudkov, A.V., Takahashi, J.S., and Antoch, M.P., Circadian sensitivity to the chemotherapeutic agent cyclophosphamide depends on the functional status of the CLOCK/BMAL1 transactivation complex, Proc. Natl. Acad. Sci. U.S.A., 2005, vol. 102, no. 10, pp. 3407–3412. doi 10.1073/pnas.0409897102
Haeussler, M., Raney, B.J., Hinrichs, A.S., Clawson, H., Zweig, A.S., Karolchik, D., Casper, J., Speir, M.L., Haussler, D., and Kent, W.J., Navigating protected genomics data with UCSC genome browser in a box, Bioinformatics, 2015, vol. 31, no. 5, pp. 764–766. doi 10.1093/bioinformatics/btu712
Haus, E., Chronobiology of hemostasis and inferences for the chronotherapy of coagulation disorders and thrombosis prevention, Adv. Drug Deliv. Rev, 2007, vol. 59, nos. 9/10, pp. 966–984. doi 10.1016/j.addr.2006.11.002
Hayashi, F., Watanabe, M., Nanba, T., Inoue, N., Akamizu, T., and Iwatani, Y., Association of the–31C/T functional polymorphism in the interleukin-1beta gene with the intractability of Graves’ disease and the proportion of T helper type 17 cells, Clin. Exp. Immunol., 2009, vol. 158, no. 3, pp. 281–286. doi 10.1111/j.1365-2249.2009.04034.x
Hirayama, S., Soda, S., Ito, Y., Matsui, H., Ueno, T., Fukushima, Y., Ohmura, H., Hanyu, O., Aizawa, Y., and Miida, T., Circadian change of serum concentration of small dense LDL-cholesterol in type 2 diabetic patients, Clin. Chim. Acta, 2010, vol. 411, nos. 3–4, pp. 253–257.
Hofstra, W.A. and de Weerd, A.W., The circadian rhythm and its interaction with human epilepsy: A review of literature, Sleep Med. Rev, 2009, vol. 13, no. 6, pp. 413–420. doi 10.1016/j.smrv.2009.01.002
Hunninghake, G.M., Cho, M.H., Tesfaigzi, Y., Soto-Quiros, M.E., Avila, L., Lasky-Su, J., Stidley, C., Melen, E., Soderhall, C., Hallberg, J., Kull, I., Kere, J., Svartengren, M., Pershagen, G., et al., MMP12, lung function, and COPD in high-risk populations, N. Engl. J. Med., 2009, vol. 361, no. 27, pp. 2599–2608. doi 10.1056/NEJMoa0904006
Kavlie, A., Hiltunen, L., Rasi, V., and Prydz, H., Two novel mutations in the human coagulation factor VII promoter, Thromb. Haemost., 2003, vol. 90, no. 2, pp. 194–205. doi 10.1160/TH02-09-0050
Kaya, B., Unal, S., Karabulut, A.B., and Turkoz, Y., Altered diurnal variation of nitric oxide production in patients with panic disorder, Tohoku J. Exp. Med., 2004, vol. 204, no. 2, pp. 147–154. doi 10.1620/tjem.204.147
Kouri, V.P., Olkkonen, J., Kaivosoja, E., Ainola, M., Juhila, J., Hovatta, I., Konttinen, Y.T., and Mandelin, J., Circadian timekeeping is disturbed in rheumatoid arthritis at molecular level, PLoS One, 2013, vol. 8, no. 1, e54049. doi 10.1371/journal.pone.0054049
Laughlin, G.A., Dominguez, C.E., and Yen, S.S., Nutritional and endocrinemetabolic aberrations in women with functional hypothalamic amenorrhea, J. Clin. Endocrinol. Metab., 1998, vol. 83, no. 1, pp. 25–32. doi 10.1210/jcem.83.1.4502
Manetti, M., Ibba-Manneschi, L., Fatini, C., Guiducci, S., Cuomo, G., Bonino, C., Bazzichi, L., Liakouli, V., Giacomelli, R., Abbate, R., Bombardieri, S., Montecucco, C., Valentini, G., and Matucci-Cerinic, M., Association of a functional polymorphism in the matrix metalloproteinase-12 promoter region with systemic sclerosis in an italian population, J. Rheumatol., 2010, vol. 37, no. 9, pp. 1852–1857. doi 10.3899/jrheum.100237
Marckmann, P., Sandstrom, B., and Jespersen, J., Dietary effects on circadian fluctuation in human blood coagulation factor VII and fibrinolysis, Atherosclerosis, 1993, vol. 101, no. 2, pp. 225–234. doi 10.1016/0021-9150(93)90119-F
Martianov, I., Viville, S., and Davidson, I., RNA polymerase IItranscription in murine cells lacking the TATA binding protein, Science, 2002, vol. 298, no. 5595, pp. 1036–1039. doi 10.1126/science.1076327
Martinez-Carrillo, D.N., Garza-Gonzalez, E., Betancourt-Linares, R., Monico-Manzano, T., Antunez-Rivera, C., Roman-Roman, A., Flores-Alfaro, E., Illades-Aguiar, B., and Fernandez-Tilapa, G., Association of IL1B -511C/–31T haplotype and Helicobacter pylori vaca genotypes with gastric ulcer and chronic gastritis, BMC Gastroenterol., 2010, vol. 10, p. 126. doi 10.1186/1471-230X-10-126
Matsunaga, A., Sasaki, J., Han, H., Huang, W., Kugi, M., Koga, T., Ichiki, S., Shinkawa, T., and Arakawa, K., Compound heterozygosity for an apolipoprotein A1 gene promoter mutation and a structural nonsense mutation with apolipoprotein A1 deficiency, Arterioscler. Thromb. Vasc. Biol., 1999, vol. 19, no. 2, pp. 348–355. doi 10.1161/01.ATV.19.2.348
Mereness, A.L., Murphy, Z.C., and Sellix, M.T., Developmental programming by androgen affects the circadian timing system in female mice, Biol. Reprod., 2015, vol. 92, no. 4, p. 88. doi 10.1095/biolreprod.114.126409
Mogno, I., Vallania, F., Mitra, R., and Cohen, B., TATA is a modular component of synthetic promoters, Genome Res., 2010, vol. 20, no. 10, pp. 1391–1397. doi 10.1101/gr.106732.110
Mullegama, S.V., Pugliesi, L., Burns, B., Shah, Z., Tahir, R., Gu, Y., Nelson, D.L., and Elsea, S.H., MBD5 haploinsufficiency is associated with sleep disturbance and disrupts circadian pathways common to Smith–Magenis and fragile X syndromes, Eur. J. Hum. Genet., 2015, vol. 23, no. 6, pp. 781–789. doi 10.1038/ejhg.2014.200
Ohdo, S., Inoue, K., Yukawa, E., Higuchi, S., Nakano, S., and Ogawa, N., Chronotoxicity of methotrexate in mice and its relation to circadian rhythm of DNA synthesis and pharmacokinetics, Jpn. J. Pharmacol., 1997, vol. 75, no. 3, pp. 283–290. doi 10.1254/jjp.75.283
Oishi, K., Koyanagi, S., and Ohkura, N., Circadian mRNA expression of coagulation and fibrinolytic factors is organdependently disrupted in aged mice, Exp. Gerontol., 2011, vol. 46, no. 12, pp. 994–999. doi 10.1016/j.exger.2011.09.003
Oka, K., Belalcazar, L.M., Dieker, C., Nour, E.A., Nuno-Gonzalez, P., Paul, A., Cormier, S., Shin, J.K., Finegold, M., and Chan, L., Sustained phenotypic correction in a mouse model of hypoalphalipoproteinemia with a helper-dependent adenovirus vector, Gene Ther., 2007, vol. 14, no. 3, pp. 191–202. doi 10.1038/sj.gt.3302819
Padmanabhan, K., Robles, M.S., Westerling, T., and Weitz, C.J., Feedback regulation of transcriptional termination by the mammalian circadian clock period complex, Science, 2012, vol. 337, no. 6094, pp. 599–602. doi 10.1126/science.1221592
Philips, S., Richter, A., Oesterreich, S., Rae, J.M., Flockhart, D.A., Perumal, N.B., and Skaar, T.C., Functional characterization of a genetic polymorphism in the promoter of the ESR2 gene, Horm. Cancer, 2012, vol. 3, nos. 1/2, pp. 37–43. doi 10.1007/s12672-011-0086-2
Pivovarova, O., Jurchott, K., Rudovich, N., Hornemann, S., Ye, L., Mockel, S., Murahovschi, V., Kessler, K., Seltmann, A.C., Maser-Gluth, C., Mazuch, J., Kruse, M., Busjahn, A., Kramer, A., and Pfeiffer, A.F., Changes of dietary fat and carbohydrate content alter central and peripheral clock in humans, J. Clin. Endocrinol. Metab., 2015, vol. 100, no. 6, pp. 2291–2302. doi 10.1210/jc.2014-3868
Plengpanich, W., Le Goff, W., Poolsuk, S., Julia, Z., Guerin, M., and Khovidhunkit, W., CETP deficiency due to a novel mutation in the CETP gene promoter and its effect on cholesterol efflux and selective uptake into hepatocytes, Atherosclerosis, 2011, vol. 216, no. 2, pp. 370–373. doi 10.1016/j.atherosclerosis.2011.01.051
Podkolodnaya, O.A. and Podkolodnyi, N.L., RF Patent no. 20133621533, 2013.
Ponomarenko, P.M., Ponomarenko, M.P., Drachkova, I.A., Lysova, M.V., Arshinova, T.V., Savinkova, L.K., and Kolchanov, N.A., Prediction of the affinity of the TATA-binding protein to TATA boxes with single nucleotide polymorphisms, Mol. Biol. (Moscow), 2009, vol. 43, no. 3, pp. 472–479.
Ponomarenko, M., Rasskazov, D., Arkova, O., Ponomarenko, P., Suslov, V., Savinkova, L., and Kolchanov, N.A., How to use SNP_TATA_Comparator to find a significant change in gene expression caused by the regulatory SNP of this gene’s promoter via a change in affinity of the TATAbinding protein for this promoter, Biomed. Res. Int., 2015, vol. 359835. doi 10.1155/2015/359835
Rasskazov, D.A., Gunbin, K.V., Ponomarenko, P.M., Vishnevskii, O.V., Ponomarenko, M.P., and Afonnikov, D.A., SNP_TATA_Comparator: Web-service for comparing SNPs within the gene promoters associated with human diseases, using the equation of equilibrium binding of the TBP/TATA complex, Vavilovskii Zh. Genet. Sel., 2013, vol. 17, no. 4/1, pp. 599–606.
Royston, S., Yasui, N., Kondilis, A.G., Lord, S.V., Katzenellenbogen, J.A., and Mahoney, M.M., ESR1 and ESR2 differentially regulate daily and circadian activity rhythms in female mice, Endocrinology, 2014, vol. 155, no. 7, pp. 2613–2623. doi 10.1210/en.2014-1101
Savinkova, L.K., Ponomarenko, M.P., Ponomarenko, P.M., Drachkova, I.A., Lysova, M.V., Arshinova, T.V., and Kolchanov, N.A., TATA box polymorphisms in human gene promoters and associated hereditary pathologies, Biochemistry (Moscow), 2009, vol. 74, no. 2, pp. 117–129.
Savinkova, L.K., Drachkova, I.A., Arshinova, T.V., Ponomarenko, P.M., Ponomarenko, M.P., and Kolchanov, N.A., An experimental verification of the predicted effects of promoter TATA-box polymorphisms associated with human diseases on interactions between the TATA boxes and TATA-binding protein, PLoS One, 2013, vol. 8, no. 2. doi 10.1371/journal.pone.0054626
Sherry, S.T., Ward, M.H., Kholodov, M., Baker, J., Phan, L., Smigielski, E.M., and Sirotkin, K., dbSNP: The NCBI database of genetic variation, Nucleic Acids Res., 2001, vol. 29, no. 1, pp. 308–311. doi 10.1093/nar/29.1.308
Sieuwerts, A.M., Ansems, M., Look, M.P., Span, P.N., de Weerd, V., van Galen, A., Foekens, J.A., Adema, G.J., and Martens, J.W., Clinical significance of the nuclear receptor co-regulator DC-SCRIPT in breast cancer: An independent retrospective validation study, Breast Cancer Res., 2010, vol. 12, no. 6, p. R103. doi 10.1186/bcr2786
Starodubtseva, N.L., Sobolev, V.V., Soboleva, A.G., Nikolaev, A.A., and Bruskin, S.A., Genes expression of metalloproteinases (MMP-1, MMP-2, MMP-9, and MMP-12) associated with psoriasis, Russ. J. Genet., 2011, vol. 47, no. 9, pp. 1117–1123.
Sun, A.H., Wang, Z.M., Xiao, S.Z., Li, Z.J., Li, J.Y., and Kong, L.S., Red cell basic ferritin concentration in sensorineural hearing loss, ORL J. Otorhinolaryngol. Relat. Spec., 1991, vol. 53, no. 5, pp. 270–272.
Tang, J.Q., Fan, Q., Wan, Y.L., Liu, Y.C., Wang, X., Wu, T., Pan, Y.S., Wu, W.H., and Zhu, J., Ectopic expression and clinical significance of tissue factor/coagulation factor VII complex in colorectal cancer, Beijing Da Xue Xue Bao, 2009, vol. 41, no. 5, pp. 531–536. doi 10.3969/j.issn.1671-167x.2009.05.005
Thio, D., Prasad, V., Anslow, P., and Lennox, P., Marrow proliferation as a cause of hearing loss in beta-thalassaemia major, J. Laryngol. Otol., 2008, vol. 122, no. 11, pp. 1253–1256. doi 10.1017/S0022215107000874
Unger, E.L., Earley, C.J., and Beard, J.L., Diurnal cycle influences peripheral and brain iron levels in mice, J. Appl. Physiol. (1985), 2009, vol. 106, no. 1, pp. 187–193. doi 10.1152/japplphysiol.91076.2008
Waardenberg, A.J., Basset, S.D., Bouveret, R., and Harvey, R.P., CompGO: An R package for comparing and visualizing gene ontology enrichment differences between dna binding experiments, BMC Bioinf., 2015, vol. 16, no. 1, p. 275. doi 10.1186/s12859-015-0701-2
Wang, Y., Kato, N., Hoshida, Y., Yoshida, H., Taniguchi, H., Goto, T., Moriyama, M., Otsuka, M., Shiina, S., Shiratori, Y., Ito, Y., and Omata, M., Interleukin-1beta gene polymorphisms associated with hepatocellular carcinoma in hepatitis C virus infection, Hepatology, 2003, vol. 37, no. 1, pp. 65–71. doi 10.1053/jhep.2003.50017
Wang, J., Luo, Y., Wang, K., Wang, Y., Zhang, X., Teng, H., and Sun, Z., Clockcontrolled StAR’s expression and corticosterone production contribute to the endotoxemia immune response, Chronobiol. Int., 2015, vol. 32, no. 3, pp. 358–367. doi 10.3109/07420528.2014.982284
Wu, Y., Zhou, J., Van Heerikhuize, J., Jockers, R., and Swaab, D., and Decreased MT1 melatonin receptor expression in the suprachiasmatic nucleus in aging and Alzheimer’s disease, Neurobiol. Aging, 2007, vol. 28, no. 8, pp. 1239–1247. doi 10.1016/j.neurobiolaging.2006.06.002
Wu, K., Zhou, X., Zheng, F., Xu, X., Lin, Y., and Yang, J., Influence of interleukin-1 beta genetic polymorphism, smoking and alcohol drinking on the risk of non-small cell lung cancer, Clin. Chim. Acta, 2010, vol. 411, nos. 19–20, pp. 1441–1446. doi 10.1016/j.cca.2010.05.035
Yamazaki, H., Takeoka, M., Kitazawa, M., Ehara, T., Itano, N., Kato, H., and Taniguchi, S., ASC plays a role in the priming phase of the immune response to type II collagen in collagen-induced arthritis, Rheumatol. Int., 2012, vol. 32, no. 6, pp. 1625–1632. doi 10.1007/s00296-011-1825-y
Yang, M., Laflamme, K., Gotea, V., Joiner, C.H., Seidel, N.E., Wong, C., Petrykowska, H.M., Lichtenberg, J., Lee, S., Welch, L., Gallagher, P.G., Bodine, D.M., and Elnitski, L., Genome-wide detection of a TFIID localization element from an initial human disease mutation, Nucleic Acids Res., 2011, vol. 39, no. 6, pp. 2175–2187. doi 10.1093/nar/gkq1035
Yoo, S.S., Jin, C., Jung, D.K., Choi, Y.Y., Choi, J.E., Lee, W.K., Lee, S.Y., Lee, J., Cha, S.I., Kim, C.H., Seok, Y., Lee, E., and Park, J.Y., Putative functional variants of XRCC1 identified by RegulomeDB were not associated with lung cancer risk in a Korean population, Cancer Genet., 2015, vol. 208, nos. 1–2, pp. 19–24. doi 10.1016/j.cancergen.2014.11.004
Zerbino, D.R., Wilder, S.P., Johnson, N., Juettemann, T., and Flicek, P.R., The Ensembl regulatory build, Genome Biol., 2015, vol. 16, p. 56. doi 10.1186/s13059-015-0621-5
Zhang, R., Lahens, N.F., Ballance, H.I., Hughes, M.E., and Hogenesch, J.B., A circadian gene expression atlas in mammals: Implications for biology and medicine, Proc. Natl. Acad. Sci. U.S.A., 2014, vol. 111, no. 45, pp. 16219–16224. doi 10.1073/pnas.1408886111
Zukunft, J., Lang, T., Richter, T., Hirsch-Ernst, K.I., Nussler, A.K., Klein, K., Schwab, M., Eichelbaum, M., and Zanger, U.M., A natural CYP2B6 TATA box polymorphism (–82T → C) leading to enhanced transcription and relocation of the transcriptional start site, Mol. Pharmacol., 2005, vol. 67, no. 5, pp. 1772–1782. doi 10.1124/mol.104.008086
Author information
Authors and Affiliations
Corresponding author
Additional information
Original Russian Text © D.A. Rasskazov, N.L. Podkolodnyy, O.A. Podkolodnaya, N.N. Tverdokhleb, V.V. Suslov, L.K. Savinkova, P.M. Ponomarenko, M.P. Ponomarenko, 2015, published in Vavilovskii Zhurnal Genetiki i Selektsii, 2015, Vol. 19, No. 6, pp. 691–698.
Rights and permissions
About this article
Cite this article
Rasskazov, D.A., Podkolodnyy, N.L., Podkolodnaya, O.A. et al. Biomedical and candidate SNP markers of chronopathologies can significantly change the affinity of the ТАТА-binding protein to the promoters of human genes. Russ J Genet Appl Res 6, 738–748 (2016). https://doi.org/10.1134/S207905971607011X
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1134/S207905971607011X